https://www.databridgemarketresearch.com/reports/global-ocular-loteprednol-market Redefining Steroid Eye Treatments: Market Outlook The Ocular Loteprednol market is poised for consistent growth as clinicians increasingly prioritize safety alongside efficacy. With the 2025 forecast showing the market crossing the USD 105 million mark, the shift toward "soft" steroids is no longer just a trend but a standard of care. While the entry of generic versions from players like Lupin and Sun Pharma is increasing price competition, it is also making these vital therapies accessible to a broader patient base globally.